Home  Clinical trials Products in Development AZD7325
|
|
A number of clinical trials with AZD7325 Ongoing studies are currently in progress.
More studies will be added in due course. Additional AZD7325 Ongoing study information is available on ClinicalTrials.gov. | Study Number | Study Phase | Start Date | Recruitment Status | | D1140C00002 | Phase I | 26 Mar 2008 | Recruiting | | A Phase 1, Single-Center, Randomized, Double-Blind, Pacebo-Controlled, Study to Assess the Safetly, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD7325 When Given in Multiple Ascending Oral Doses in Heathly Male and Healthy Female Subjects of Non-child Bearing Potential | | D1140C00003 | Phase I | 16 Jun 2008 | Recruiting | | A phase 1, single centre, single dose, double-blind, double-dummy, four-way crossover, placebo-controlled, randomized study to investigate the effects of AZD7325 on sedation, cognition and EEG in comparison with lorazepam in healthy male volunteers. | | D1140C00007 | Phase I | 25 Feb 2008 | Completed | | An open label positron emission tomography (PET) study with (11C)flumazenil to determine central GABAA receptor occupancy of AZD7325 after oral administration to healthy volunteeers. |
|
|
|
|